02/03 MARKET MOVERS: HGSI-Nasdaq, TSTR-Nasdaq, VIO-TSX Venture
Greetings,
* Human Genome Sciences (HGSI-Nasdaq, Quote, http://www.hgsi.com) Human Genome has several projects underway, one of which has recently caught the markets attention with an announcement of it’s first shipment of ABthrax, a treatment for anthrax inhalation, to the U.S. Strategic National Stockpile. The shipment of 20,000 doses is expected to bring in approximately $150 Million in revenue. HGSI has several other products in late stage development, and a promising mid-stage pipeline trial underway (see web site for details). Additionally, the company has substantial financial rights to a number of products being developed by GlaxoSmithKline. This first break-through announcement is sure to be followed up by others, giving investors reason to send share prices much higher.
* TerreStar Networks (TSTR-Nasdaq, Quote, http://www.terrestar.com) TerreStar is developing a unique, secure satellite communications device to be used in voice, data and video services around the globe. The company has had its share of problems, as witnessed in the deterioration of its share price. From a 52 week high of $6.55, it has been reduced to penny stock status, however we feel it is a hot penny stock to be watched closely as they continue to progress in the development and marketing of their handset.
* Vior Mining (VIO-TSX Venture, Quote, http://www.vior.ca) This Canadian junior resource penny stock holds a vast array of precious metal (gold and silver) projects in Quebec, Canada. As the price of gold continues to flirt with the $1,000 level, gold penny stocks are poised to break into a spectacular bull run, specifically those gold junior companies with significant deposits. VIO has a significant 2.15 million ounces in the measured, indicated and inferred category, under development. At only 0.055, we see significant upside to VIO as they advance their gold project.
Bringing you the hottest penny stocks on the market,
Penny Stock Rockets